Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Center for Tissue Engineering, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Ann Surg Oncol. 2020 Dec;27(13):5267-5276. doi: 10.1245/s10434-020-08720-2. Epub 2020 Jun 18.
Extremity lymphedema can occur bilaterally with different severities on each side. The aim of this study is to investigate the treatment outcomes of such patients with bilateral extremity lymphedema of different severities.
Between 2013 and 2017, patients with bilateral extremity lymphedema of different severities according to the Taiwan Lymphoscintigraphy Staging (TLS) system were retrospectively reviewed. Ipsilateral vascularized lymph node transplantation (VLNT) was indicated in TLS total obstruction and contralateral lymphovenous anastomosis (LVA) in TLS partial obstruction with patent lymphatic vessels on indocyanine green lymphography. Outcomes were assessed using circumference improvement, frequency of cellulitis, and lymphedema-specific quality of life (LYMQoL) questionnaires.
A total of 10 patients with bilateral extremity lymphedema with median age of 63 (range 12-75) years were included. The median symptom duration of the lymphedematous limb was 60 (range 36-168) months and 12 (range 1-60) months in the VLNT and LVA group, respectively (p < 0.05). At average follow-up of 37.5 (range 14-58) months, the average limb circumference improvement was 2.4 (range - 3.3 to 7.8) cm in the VLNT group and 2.3 (range 0.3-7) cm in the LVA group (p = 1). The median episodes of cellulitis decreased significantly from 4 to 0.5 and 1 to 0 times/year in the VLNT and LVA group, respectively (p = 0.02, p = 0.06). The overall LYMQoL score improved from 4.5 preoperatively to 7.5 postoperatively (p < 0.01).
Limb-specific VLNT and LVA selected by TLS effectively treated bilateral extremity lymphedema with different severities.
肢体淋巴水肿可能双侧发生,两侧的严重程度不同。本研究旨在探讨此类双侧不同严重程度肢体淋巴水肿患者的治疗效果。
回顾性分析 2013 年至 2017 年间双侧不同严重程度肢体淋巴水肿患者,根据台湾淋巴闪烁成像分期(TLS)系统进行评估。同侧血管化淋巴结移植(VLNT)适用于 TLS 总阻塞,对侧淋巴管静脉吻合术(LVA)适用于 TLS 部分阻塞且吲哚菁绿淋巴造影显示有通畅淋巴管。采用周长改善、蜂窝织炎发作频率和淋巴水肿特异性生活质量(LYMQoL)问卷评估治疗效果。
共纳入 10 例双侧肢体淋巴水肿患者,平均年龄 63 岁(12-75 岁)。患病肢体的中位症状持续时间为 60 个月(36-168 个月),VLNT 和 LVA 组分别为 12 个月(1-60 个月)(p<0.05)。平均随访 37.5 个月(14-58 个月)后,VLNT 组和 LVA 组的平均肢体周长改善分别为 2.4 厘米(-3.3 至 7.8 厘米)和 2.3 厘米(0.3-7 厘米)(p=1)。VLNT 组和 LVA 组的蜂窝织炎发作频率分别从 4 次/年显著降至 0.5 次/年和 1 次/年降至 0 次/年(p=0.02,p=0.06)。总体 LYMQoL 评分从术前的 4.5 分提高到术后的 7.5 分(p<0.01)。
根据 TLS 选择的肢体特异性 VLNT 和 LVA 可有效治疗双侧不同严重程度的肢体淋巴水肿。